Technical Analysis for OCUL - Ocular Therapeutix, Inc.

Grade Last Price % Change Price Change
grade F 3.94 -0.25% -0.01
OCUL closed down 0.25 percent on Friday, January 18, 2019, on 49 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical OCUL trend table...

Date Alert Name Type % Chg
Jan 18 Bollinger Band Squeeze Range Contraction 0.00%
Jan 18 BB Squeeze Started Range Contraction 0.00%
Jan 18 Down 3 Days in a Row Weakness 0.00%
Jan 16 Spinning Top Other -0.51%
Jan 15 Narrow Range Bar Range Contraction -1.25%
Jan 15 NR7 Range Contraction -1.25%
Jan 14 Inside Day Range Contraction 0.00%
Jan 14 Wide Bands Range Expansion 0.00%
Jan 14 Down 3 Days in a Row Weakness 0.00%
Jan 11 Wide Bands Range Expansion -0.25%

Older signals for OCUL ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Ocular Therapeutix, Inc., a development stage biopharmaceutical company, focuses on the development and commercialization of therapies based on its proprietary hydrogel platform technology for treating eye diseases and conditions. The company offers ReSure Sealant, a topical liquid hydrogel that creates a sealant to prevent post-surgical leakage from clear corneal incisions made during cataract surgery Its lead product candidates comprise OTX-DP, which is in Phase III clinical trials for the treatment of post-surgical ocular inflammation and pain; and OTX-TP that is in Phase II clinical trials for the treatment of glaucoma and ocular hypertension. The company's earlier stage product candidates include OTX-DP, which is in Phase II clinical trials for the treatment of allergic conjunctivitis; OTX-MP that has completed Phase I clinical trials for the treatment of bacterial conjunctivitis; and Anti-VEGF hydrogel depot, which is in preclinical testing for the treatment of wet AMD. Ocular Therapeutix, Inc. sells its ReSure Sealant through a network of independent medical device distributors in the United States. The company was founded in 2006 and is headquartered in Bedford, Massachusetts.
Is OCUL a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 8.28
52 Week Low 3.55
Average Volume 590,738
200-Day Moving Average 6.0769
50-Day Moving Average 4.9264
20-Day Moving Average 4.0755
10-Day Moving Average 4.019
Average True Range 0.3146
ADX 32.99
+DI 10.8899
-DI 22.6425
Chandelier Exit (Long, 3 ATRs ) 4.2862
Chandelier Exit (Short, 3 ATRs ) 4.4938
Upper Bollinger Band 4.3611
Lower Bollinger Band 3.7899
Percent B (%b) 0.26
BandWidth 14.015458
MACD Line -0.2965
MACD Signal Line -0.3303
MACD Histogram 0.0338
Fundamentals Value
Market Cap 114.48 Million
Num Shares 29.1 Million
EPS -2.15
Price-to-Earnings (P/E) Ratio -1.83
Price-to-Sales 88.04
Price-to-Book 3.48
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.20
Resistance 3 (R3) 4.19 4.11 4.15
Resistance 2 (R2) 4.11 4.04 4.11 4.14
Resistance 1 (R1) 4.02 4.00 3.98 4.03 4.12
Pivot Point 3.94 3.94 3.92 3.94 3.94
Support 1 (S1) 3.85 3.87 3.81 3.86 3.76
Support 2 (S2) 3.77 3.83 3.77 3.74
Support 3 (S3) 3.68 3.77 3.73
Support 4 (S4) 3.69